Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Inbar-Feigenberg

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Trials|December 10, 2021
Correction to: Establishing a core outcome set for mucopolysaccharidoses (MPS) in children: study protocol for a rapid literature review, candidate outcomes survey, and Delphi surveysAlison H Howie, Kylie Tingley, Michal Inbar-Feigenberg, et al.
Journal of Inherited Metabolic Disease|February 26, 2021
New insights into carnitine-acylcarnitine translocase deficiency from 23 cases: Management challenges and potential therapeutic approachesBryony Ryder, Michal Inbar-Feigenberg, Emma Glamuzina, et al.
Orphanet Journal of Rare Diseases|October 24, 2024
Review of clinical trials and guidelines for children and youth with mucopolysaccharidosis: outcome selection and measurementAlison H Howie, Kylie Tingley, Michal Inbar-Feigenberg, et al.
American Journal of Human Genetics|May 6, 2017
CHARGE and Kabuki Syndromes: Gene-Specific DNA Methylation Signatures Identify Epigenetic Mechanisms Linking These Clinically Overlapping ConditionsDarci T Butcher, Cheryl Cytrynbaum, Andrei L Turinsky, et al.
The Patient|July 20, 2021
Family Experiences with Care for Children with Inherited Metabolic Diseases in Canada: A Cross-Sectional SurveyAndrea J Chow, Michael Pugliese, Laure A Tessier, et al.
JIMD Reports|September 3, 2025
Metabolic Control and Frequency of Clinical Monitoring Among Canadian Children With Phenylalanine Hydroxylase Deficiency: A Retrospective Cohort StudyNataliya Yuskiv, Ammar Saad, Beth K Potter, et al.
Human Molecular Genetics|November 9, 2023
Clinical features, functional consequences, and rescue pharmacology of missense GRID1 and GRID2 human variantsJames P Allen, Kathryn B Garber, Riley Perszyk, et al.
Orphanet Journal of Rare Diseases|June 11, 2026
The impacts of caring for children with inherited metabolic diseases for families: a cross-sectional studyAndrea J Chow, Isabel Jordan, Nicole Pallone, et al.
Genome Medicine|July 2, 2025
Clinical applications of and molecular insights from RNA sequencing in a rare disease cohortJamie C Stark, Neta Pipko, Yijing Liang, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 5, 2024
Family-centred care interventions for children with chronic conditions: A scoping reviewAndrea J Chow, Ammar Saad, Zobaida Al-Baldawi, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Trials|December 10, 2021
Correction to: Establishing a core outcome set for mucopolysaccharidoses (MPS) in children: study protocol for a rapid literature review, candidate outcomes survey, and Delphi surveysAlison H Howie, Kylie Tingley, Michal Inbar-Feigenberg, et al.
Journal of Inherited Metabolic Disease|February 26, 2021
New insights into carnitine-acylcarnitine translocase deficiency from 23 cases: Management challenges and potential therapeutic approachesBryony Ryder, Michal Inbar-Feigenberg, Emma Glamuzina, et al.
Orphanet Journal of Rare Diseases|October 24, 2024
Review of clinical trials and guidelines for children and youth with mucopolysaccharidosis: outcome selection and measurementAlison H Howie, Kylie Tingley, Michal Inbar-Feigenberg, et al.
American Journal of Human Genetics|May 6, 2017
CHARGE and Kabuki Syndromes: Gene-Specific DNA Methylation Signatures Identify Epigenetic Mechanisms Linking These Clinically Overlapping ConditionsDarci T Butcher, Cheryl Cytrynbaum, Andrei L Turinsky, et al.
The Patient|July 20, 2021
Family Experiences with Care for Children with Inherited Metabolic Diseases in Canada: A Cross-Sectional SurveyAndrea J Chow, Michael Pugliese, Laure A Tessier, et al.
JIMD Reports|September 3, 2025
Metabolic Control and Frequency of Clinical Monitoring Among Canadian Children With Phenylalanine Hydroxylase Deficiency: A Retrospective Cohort StudyNataliya Yuskiv, Ammar Saad, Beth K Potter, et al.
Human Molecular Genetics|November 9, 2023
Clinical features, functional consequences, and rescue pharmacology of missense GRID1 and GRID2 human variantsJames P Allen, Kathryn B Garber, Riley Perszyk, et al.
Orphanet Journal of Rare Diseases|June 11, 2026
The impacts of caring for children with inherited metabolic diseases for families: a cross-sectional studyAndrea J Chow, Isabel Jordan, Nicole Pallone, et al.
Genome Medicine|July 2, 2025
Clinical applications of and molecular insights from RNA sequencing in a rare disease cohortJamie C Stark, Neta Pipko, Yijing Liang, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 5, 2024
Family-centred care interventions for children with chronic conditions: A scoping reviewAndrea J Chow, Ammar Saad, Zobaida Al-Baldawi, et al.
Pageof 5